openPR Logo
Press release

Insights into Listeria Monocytogenes Infections Treatment Market 2024: Size, Share, Growth, Trends, and Forecast to 2033

04-20-2024 07:41 AM CET | Health & Medicine

Press release from: The Business research company

Listeria Monocytogenes Treatment Market

Listeria Monocytogenes Treatment Market

The listeria monocytogenes infections treatment market size has grown strongly in recent years. It will grow from $4.52 billion in 2023 to $4.79 billion in 2024 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increased food safety regulations, increased incidence of foodborne illnesses, advancements in diagnostics, awareness programs and education, healthcare infrastructure development..

The listeria monocytogenes infections treatment market size is expected to see strongly grown in the next few years. It will grow to $5.86 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to globalization of food supply chains, research and development in antimicrobials, changing dietary patterns, international collaboration in healthcare, public health preparedness.. Major trends in the forecast period include application of combination therapies, enhanced diagnostic tools, focus on prevention and prophylaxis, collaborative research initiatives, regulatory framework development..

Market Overview -
Listeria monocytogenes infection treatment refers to the medical interventions and therapeutic measures employed to combat and manage infections caused by the bacterium listeria monocytogenes. Listeria monocytogenes is a pathogenic bacterium that can cause a severe illness known as listeriosis in humans. Listeriosis typically occurs when individuals consume contaminated food or beverages that contain listeria monocytogenes.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13092&type=smp

Rising Incidence Of Foodborne Diseases Drive The Listeria Monocytogenes Infection Treatment Market
The rising incidence of foodborne diseases is expected to propel the growth of the listeria monocytogenes infection treatment going forward. Foodborne diseases, also known as foodborne illnesses or food poisoning, refer to diseases caused by consuming contaminated food or beverages. Listeria monocytogenes infections caused by the bacterium Listeria monocytogenes, can be a significant concern in foodborne illnesses because this bacterium can contaminate various foods. The treatment for listeria monocytogenes infections reduces the risk factors and severity associated with the disease. For instance, in December 2022, according to the European Food Safety Authority, an Italy-based independent agency for providing scientific advice on food and feed safety, nutrition, and related issues, there were around 4,005 foodborne incidents in 2021, an increase of 29.8% compared to 2020. Therefore, the rising incidence of foodborne diseases is driving the growth of the listeria monocytogenes infection treatment.

Competitive Landscape -
Major companies operating in the listeria monocytogenes infections treatment market report are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, AstraZeneca plc, GlaxoSmithKline plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Biogen Inc., Vertex Pharmaceuticals Incorporated, Fresenius Kabi AG, Aurobindo Pharma Ltd, Amneal Pharmaceuticals LLC, Lupin Ltd., ZydusCadila Health Care Ltd., Emergent Bio Solutions Inc., Wockhardt Ltd., Hainan Poly Pharm Co. Ltd., Novel Laboratories Inc., Bionpharma Inc., LimmaTech Biologics AG

Innovative Solutions Driving Growth In The Listeria Monocytogenes Infections Treatment Market
Major companies operating in the listeria monocytogenes infections treatment market are focusing on developing innovative products such as Microgen Listeria-ID to drive revenues in the market. Microgen Listeria-ID is a microbiological test designed to detect and confirm the presence of Listeria bacteria in food and other environmental samples. This comprehensive identification technique enables laboratories to identify and differentiate Listeria spp species without additional materials correctly. For instance, in April 2023, Gold Standard Diagnostics, a US-based company specializing in diagnostic test systems and services, launched Microgen Listeria-ID. The primary use of Microgen Listeria-ID is to identify Listeria monocytogenes for quality control and monitoring purposes in food processing facilities. Microgen Listeria-ID is known for its rapid and reliable identification of Listeria species. It can provide results in a shorter time compared to traditional culture-based methods.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/listeria-monocytogenes-infections-treatment-global-market-report

Key Segments -
The listeria monocytogenes infections treatment market covered in this report is segmented -
1) By Drug Class: Ampicillin, Gentamicin, Vancomycin, Other Drug Classes
2) By Type Of Infection: Gastroenteritis, Endocarditis, Meningitis, Bacteremia, Brain Abscess
3) By Mode Of Administration : Oral, Injectable, Other Mode Of Administrations
4) By End Users: Hospitals, Home Care, Speciality Clinics, Other End Users

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insights into Listeria Monocytogenes Infections Treatment Market 2024: Size, Share, Growth, Trends, and Forecast to 2033 here

News-ID: 3470669 • Views:

More Releases from The Business research company

Emerging Trends to Reshape the Surgical Energy Instruments Market: Innovative Technologies In Surgical Energy Instruments as a Key Influencer
Emerging Trends to Reshape the Surgical Energy Instruments Market: Innovative Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Surgical Energy Instruments Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the market size of surgical energy instruments has seen substantial growth. The market which is projected to be worth $4.68 billion in 2024, is expected to inflate to $5.2
2025-2034 Spatial omics Market Evolution: Disruptions, Innovations, and Untapped Opportunities
2025-2034 Spatial omics Market Evolution: Disruptions, Innovations, and Untapped …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Spatial omics Market Through 2025? In recent years, the size of the spatial omics market has seen rapid expansion. The estimations show an increase to $0.33 billion in 2025 from $0.3 billion in 2024, marking a compound annual growth rate (CAGR) of
Global Sigmoidoscope Market Projected to Grow at 6.1% CAGR, Reaching $3.38 Billion by 2029
Global Sigmoidoscope Market Projected to Grow at 6.1% CAGR, Reaching $3.38 Billi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Sigmoidoscope Industry Market Size Be by 2025? In recent years, there has been a significant increase in the size of the sigmoidoscope market. The market is projected to expand from $2.53 billion in 2024 to $2.67 billion in 2025, demonstrating a compound annual growth rate (CAGR)
2025-2034 Refurbished MRI Systems Market Roadmap: Insights for Competitive Advantage
2025-2034 Refurbished MRI Systems Market Roadmap: Insights for Competitive Advan …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Refurbished MRI Systems Market Size By 2025? The market size for refurbished MRI systems has experienced robust growth in the past few years. It is expected to rise from $0.77 billion in 2024 to $0.85 billion in 2025, showcasing a compound annual growth rate (CAGR)

All 5 Releases


More Releases for Listeria

Listeria Monocytogenes Test Kit Market Size, Share and Growth Report, 2034
"The Listeria monocytogenes test kit market is poised for significant growth in 2024, with an estimated market value of approximately $300 million. The market is projected to reach $500 million by 2034, driven by increasing food safety regulations and rising consumer awareness regarding foodborne illnesses. The compound annual growth rate (CAGR) for the period from 2025 to 2034 is estimated at 6.1%, reflecting a robust demand for rapid and accurate
Listeria Infections Treatment Market 2024: Key Insights and Growth Trends
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Listeria Monocytogenes Infections Treatment Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $5.86 billion In
Global Listeria Enrichment Broth Market - Opportunities & Forecasts, 2020-2029
The research report from Dhirtek Business Research and Consulting is a thorough examination of the global listeria enrichment broth market. Subject matter experts and a team of highly trained researchers have worked tirelessly to compile an original research report on the global listeria enrichment broth market. Analysts have researched the various items on the market and provided unbiased opinions on the variables that are expected to drive and constrain the
Listeria Monocytogenes Infections Treatment Market Set to Witness Steady Growth …
The Listeria Monocytogenes Infections Treatment Market research identifies challenges in the industry and identifies areas where the company can grow by expanding its consumer base. It also aids in the development of effective strategies and the making of educated market decisions. This Listeria Monocytogenes Infections Treatment market research aids in the establishment of attainable objectives in order for the business to reap significant earnings. To better comprehend current market trends,
Listeria Monocytogenes Infections Treatment Market: Information framework convey …
“The pharmaceutical industry is a multi-billion dollar business tasked with researching, developing, manufacturing and distributing drugs for human and animal use. The stakes are high; lives and money are on the line each time a new medicine is conceived. And because the process from drug conception to its delivery is a long one, it’s important that companies do the necessary research to insure that they are meeting a worthy demand
Listeria Monocytogenes Infections Treatment Market Shows Expected Growth from 20 …
Listeriosis is a dreadful common bacterial infection named listeria monocytogenes. Listeriosis spreads by consumption of contaminated food, such as ready-to-eat meats, raw or unpasteurized milk, cheeses, processed foods, vegetables, and smoked fish products. Infection with listeria Monocytogenes results in mild to severe gastroenteritis and can lead to meningitis and septicemia. In people with weak immune system it can lead to diabetes, HIV, cancer, chronic liver, and kidney disease. Additionally, listeriosis